4//SEC Filing
BJERKHOLT ERIC 4
Accession 0001415889-24-023289
CIK 0001759425other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 4:18 PM ET
Size
7.1 KB
Accession
0001415889-24-023289
Insider Transaction Report
Form 4
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-09-11−18,334→ 36,666 total→ Common Stock (18,334 underlying) - Exercise/Conversion
Common Stock
2024-09-11+18,334→ 32,804 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- [F2]The restricted stock units vest in a series of three successive equal annual installments beginning on the one-year anniversary of September 11, 2023.
Documents
Issuer
Mirum Pharmaceuticals, Inc.
CIK 0001759425
Entity typeother
Related Parties
1- filerCIK 0001197350
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 4:18 PM ET
- Size
- 7.1 KB